Publications by authors named "Barbara Bober"

Claim this Profile
P
Possible changes in glucose metabolism induced by radioligand therapy in patients with neuroendocrine neoplasms.
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Arkadiusz Lubas, Anna Drozd

Endokrynol Pol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications.
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Arkadiusz Lubas, Maciej Kołodziej

Int J Mol Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Maciej Kołodziej, Arkadiusz Lubas

Nutrients· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm.
Barbara Bober, Marek Saracyn, Arkadiusz Lubas, Maciej Kolodziej, Dorota Brodowska-Kania

Nucl Med Rev Cent East Eur· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study.
Barbara Bober, Marek Saracyn, Kornelia Zaręba, Arkadiusz Lubas, Paweł Mazurkiewicz

J Clin Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THE ROLE OF PET/CT WITH 11C-METHIONINE IN CONTEMPORARY NUCLEAR MEDICINE.
Maciej Kołodziej, Barbara Bober, Marek Saracyn, Grzegorz Kamiński

Wiad Lek· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoid Heart Disease: How to Diagnose and Treat in 2020?
Barbara Bober, Marek Saracyn, Maciej Kołodziej, Łukasz Kowalski, Elżbieta Deptuła-Krawczyk

Clin Med Insights Cardiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Human Thyrotropin Worsens Renal Cortical Perfusion and Renal Function in Patients After Total Thyroidectomy Due to Differentiated Thyroid Cancer.
Marek Saracyn, Arkadiusz Lubas, Barbara Bober, Łukasz Kowalski, Waldemar Kapusta

Thyroid· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[WSPÓŁCZESNA DIAGNOSTYKA NOWOTWORÓW NEUROENDOKRYNNYCH Current diagnostics of neuroendocrine tumors].
Barbara Bober, Martyna Zaleska, Łukasz Kowalski, Kornelia Zaręba, Marek Saracyn

Wiad Lek· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current treatment of neuroendocrine tumors].
Barbara Bober, Martyna Zaleska, Maciej Kołodziej, Elżbieta Deptuła-Krawczyk, Marek Saracyn

Wiad Lek· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of neuroendocrine tumors with radio-labeled somatostatin analogues].
Barbara Bober, Martyna Zaleska, Maciej Kołodziej, Łukasz Kowalski, Marek Saracyn

Wiad Lek· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of multilocus genetic risk score for atrial fibrillation in end-stage kidney disease patients in a Polish population.
Marek Saracyn, Bartłomiej Kisiel, Artur Bachta, Maria Franaszczyk, Dorota Brodowska-Kania, Barbara Bober

Sci Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis